{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:33:57Z","timestamp":1792773237828,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.jcrc.2026.155763","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:23:36Z","timestamp":1790789016000},"page":"155763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association of early IgM\/IgA-enriched immunoglobulin therapy with long-term survival after septic shock: A propensity-score\u2013matched multicentre cohort study"],"prefix":"10.1016","volume":"97","author":[{"given":"Alberto","family":"Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Shuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2026.155763_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2026.155763_bb0010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jcrc.2026.155763_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jcrc.2026.155763_bb0020","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.intimp.2011.08.024","article-title":"Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients","volume":"11","author":"Venet","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jcrc.2026.155763_bb0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcrc.2012.08.004","article-title":"Beneficial role of endogenous immunoglobulin subclasses and isotypes in septic shock","volume":"27","author":"Tamayo","year":"2012","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jcrc.2026.155763_bb0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/joim.12265","article-title":"Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis","volume":"276","author":"Bermejo-Mart\u00edn","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jcrc.2026.155763_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/cc1523","article-title":"The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis","volume":"6","author":"Tugrul","year":"2002","journal-title":"Crit. Care"},{"key":"10.1016\/j.jcrc.2026.155763_bb0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00540-012-1553-9","article-title":"Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study","volume":"27","author":"Toth","year":"2013","journal-title":"J. Anesth."},{"key":"10.1016\/j.jcrc.2026.155763_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcrc.2011.05.012","article-title":"Relationship between the timing of administration of IgM- and IgA-enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome","volume":"27","author":"Berlot","year":"2012","journal-title":"J. Crit. Care"},{"key":"10.1016\/j.jcrc.2026.155763_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0501-3","article-title":"The clinical efficacy of intravenous IgM-enriched immunoglobulin in sepsis or septic shock: a meta-analysis with trial sequential analysis","volume":"9","author":"Cui","year":"2019","journal-title":"Ann. Intensive Care"},{"issue":"8","key":"10.1016\/j.jcrc.2026.155763_bb0055","article-title":"IgM-enriched immunoglobulin as adjunctive therapy in adult sepsis and septic shock: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Sewify","year":"2026","journal-title":"Crit. Care Explor."},{"key":"10.1016\/j.jcrc.2026.155763_bb0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.jcrc.2026.155763_bb0065","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat. Med."},{"key":"10.1016\/j.jcrc.2026.155763_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-13-152","article-title":"Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.jcrc.2026.155763_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pds.1357","article-title":"Immortal time bias in observational studies of drug effects","volume":"16","author":"Suissa","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126003412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944126003412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:37:54Z","timestamp":1792766274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944126003412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":15,"alternative-id":["S0883944126003412"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155763","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of early IgM\/IgA-enriched immunoglobulin therapy with long-term survival after septic shock: A propensity-score\u2013matched multicentre cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2026.155763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155763"}}